NovaBay Pharmaceuticals Stock Quote NBY - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.077

Bid

Ask

Volume

1,817

0.00 Day's Range 0.00

0.065 52 Week Range 1.52

Market Cap

522.344k

Previous Close

0.077

Open

Last Trade

0.077

Last Trade Time

06:36:39

Financial Volume

VWAP

Average Volume (3m)

2,800,283

Shares Outstanding

6,529,302

Dividend Yield

PE Ratio

-0.03

Earnings Per Share (EPS)

-2.56

Revenue

14.73M

Net Profit

-16.7M

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial... NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.novabay.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

NovaBay Pharmaceuticals Inc New is listed in the Pharmaceutical Preparations sector of the American Stock Exchange with ticker NBY. The last closing price for NovaBay Pharmaceuticals was $0.08. Over the last year, NovaBay Pharmaceuticals shares have traded in a share price range of $ 0.065 to $ 1.52.

NovaBay Pharmaceuticals currently has 6,529,302 shares outstanding. The market capitalization of NovaBay Pharmaceuticals is $522,344 . NovaBay Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.03.

NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare and wound care products, announces a new and enhanced marketing program that...

NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that on April 18, 2024 it received a notice from the NYSE American LLC stating that the Company is below compliance with the NYSE...

NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses

Growth driven by efficient Avenova® direct-to-consumer e-marketing programs NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports preliminary net revenue for its eyecare and wound care...

NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results

Q4 net sales from the eyecare and wound care segment grew 10% over the prior year with higher sales from the Avenova® physician dispensed and OTC channels, and from branded wound care products...

NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and 12 months ended December 31, 2023 after market close on Tuesday, March 26...

NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023

DERMAdoctor sale reduces operating expenses and bolsters cash NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare and wound care...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.023	-23	0.1	0.1	0.065	4866725	0.08087899	CS
4	-0.0527	-40.632228219	0.1297	0.12985	0.065	2800865	0.09102918	CS
12	-0.0831	-51.9050593379	0.1601	0.1879	0.065	2800283	0.13038928	CS
26	-0.273	-78	0.35	0.3694	0.065	2175802	0.15173971	CS
52	-1.303	-94.4202898551	1.38	1.52	0.065	1504218	0.30135971	CS
156	-28.3465	-99.7290974018	28.4235	30.702	0.065	1067783	7.95641118	CS
260	-34.3	-99.776013032	34.377	167.3	0.065	1761931	29.82801574	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CSSEChicken Soup for the Soul Entertainment Inc	$ 0.253 (66.12%)	9.76M
ZPTAZapata Computing Holdings Inc	$ 1.99 (27.56%)	5.11M
IMCCIM Cannabis Corporation	$ 0.7268 (27.44%)	7
TSLRGraniteShares ETF Trust GraniteShares	$ 10.15 (25.15%)	3.62k
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 6.74 (25.05%)	3.3M
EVOEvotec SE	$ 5.07 (-33.73%)	111.7k
TSDDGraniteShares ETF Trust GraniteShares	$ 26.50 (-25.35%)	22.02k
TSLZT Rex 2X Inverse Tesla Daily Target ETF	$ 41.85 (-25.16%)	283k
ESCAEscalade Inc	$ 10.35 (-24.78%)	10
CDTGCDT Environmental Technology Investment Holdings Ltd	$ 3.03 (-19.41%)	22
CSSEChicken Soup for the Soul Entertainment Inc	$ 0.253 (66.12%)	9.76M
CYNCYNGN Inc	$ 0.1186 (4.04%)	7.19M
ZPTAZapata Computing Holdings Inc	$ 1.99 (27.56%)	5.11M
PEGYPineapple Energy Inc	$ 0.0589 (4.06%)	4.3M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 6.74 (25.05%)	3.3M